Rodríguez-Violante M, López-Ruiz M, Estrada-Bellman I, Cervantes-Arriaga A

Language: Spanish
References: 13
Page: 183-186
PDF size: 104.26 Kb.

ABSTRACT

Objective: To evaluate the feasibility in terms of time to implement a single record format and brief standardized clinical assessment of motor function in patients with Parkinson’s disease. Methods: We included 204 patients from three hospitals. The short Parkinson’s evaluation scales, the clinical impression of the severity of Parkinson’s disease and rapid scale disability evaluation were applied. Results: The mean time for application of the clinical instruments was 15 ± 1.1 min. The correlation between the instruments was acceptable and comparable with international reports. Conclusion: The structured questionnaire and clinical assessment with the selected instruments allow a full standarized assessment of patients with PD within the time frame established for care in the outpatient clinics of the participating institutions.

REFERENCES

1. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s Disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003; 157: 1015-22.

2. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68: 384-6.

3. Klein C, Schlossmacher MG. Parkinson disease, 10 years after its genetic revolution. Multiple clues to a complex disorder. Neurology 2007; 69: 2093-104.

4. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-2.

5. Marinus J, Visser M, Stiggelbout AM, Rabey JM, Martínez-Martín P, Bonuccelli U, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004; 75: 388-95.

6. Martínez-Martín P, Rodríguez-Blázquez C, Forjaz MJ, de Pedro J, Spanish- American Longitudinal PD patient study group. The clinical impression of severity index for Parkinson’s disease: international validation study. Mov Disord 2009; 24: 211-7.

7. Martínez-Martín P, Forjaz MJ, Frades B, Cubo E, de Pedro J. La Rapid Assessment Disability Scale (RAD) en Enfermedad de Parkinson. Gac Sanit 2005; 19(Suppl. 1): 68.

8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-42.

9. Movement Disorder Task Force on Rating Scales for Parkinson’s Disease. The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003; 18: 738-50.

10. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-70.

11. Martignoni E, Franchignoni F, Pasetti C, Ferriero G, Picco D. Psychometric properties of the Unified Parkinson’s Disease Rating Scale and of the Short Parkinson’s Evalaution Scale. Neurol Sci 2003; 24: 190-1.

12. Martínez-Martín P, Benito-Leon J, Burquera JA, Castro A, Linazasoro G, Martínez-Castillo JC, et al. The SCOPA-Motor scale for assessment of Parkinson’s disease is a consistent and valid measure. J Clin Epidemiol 2005; 58: 674-9.

13. Veerban D, van Rooden SM, Benit CP, van Zwet EW, Marinus J, van Hilten JJ. SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson’s disease. Parkinsonism Relat Disord 2011: 17: 632-4.